Cannabinol: Clinical Trials

2 trials of Cannabinol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 2

Follow Cannabinol: new trials by email Literature Review of Cannabinol trials Research Report on Cannabinol

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cannabinol Use in Patients With Insomnia Disorder
30 mg Cannabinol (CBN), 300 mg Cannabinol (CBN), Placebo - Insomnia Disorder
Phase 1 / Phase 2CompletedWoolcock Institute of Medical Research202022-08-242024-02-06
A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN With and Without CBD on Sleep Quality
CBN and CBD - Healthy Adults
Phase 1 / Phase 2CompletedCanopy Growth Corporation3012022-05-162023-05-03

Conditions studied

Sleep Initiation and Maintenance Disorders (1)

Sponsors

Canopy Growth Corporation (1)  ·  Woolcock Institute of Medical Research (1)

Countries

Australia (1)  ·  United States (1)

Top investigators

Brendon Yee, MBChB, FRACP, FCCP, PhD (1)  ·  Camilla Hoyos, MPH, PhD (1)  ·  Matthew T Feldner, PhD (1)

Results publications

PMID 37612115, PMID 37796540, PMID 41698831